PUBLICATIONS

P. Lovat, et al

Discovery and validation of AMBLor as a prognostic biomarker for non-ulcerated cutaneous AJCC stage I/II melanoma.

J Clin Onc, ASCO Abstract (Poster), 2023 Jun; 9573

Performance analysis of four machine learning algorithms for the accurate prediction of metastatic disease in cutaneous squamous cell carcinoma.

J Clin Onc, ASCO Abstract, 2023 Jun; e13579

S. Di Palma, A. McConnell, S. Verganti, M. Starkey

Review on canine oral melanoma: an undervalued authentic genetic model of human oral melanoma?

Vet Pathol. 2021 Mar 9:300985821996658

D.J. Klionsky, et al (P.E. Lovat author)

Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)

Autophagy. 2021 Jan;17(1):1–382

M. Antonioli, et al (P. Lovat, M. Labus, authors)

HPV sensitizes OPSCC cells to cisplatin-induced apoptosis by inhibiting autophagy through E7-mediated degradation of AMBRA1

Autophagy. 2020 Nov 23:1-14. doi: 10.1080/15548627.2020.1847444. Online ahead of print. Autophagy. 2020. PMID: 33172332

R. Ellis, et al (A. McConnell, M. Labus, P.E. Lovat authors)

Epidermal autophagy and beclin 1 regulator 1 and loricrin: a paradigm shift in the prognostication and stratification of the American Joint Committee on Cancer stage I melanomas

Br J Dermatol. 2020 Jan;182(1):156–165

D. Hill, P. Lovat

Cover Image: Invasion of a cutaneous melanoma tumour

Br J Dermatol. 2017 Aug;177(2):599

B. Carroll, et al (P.E. Lovat author)

Persistent mTORC1 signaling in cell senescence results in defects in amino acid and growth factor sensing

J Cell Biol. 2017 Jul 3;216(7):1949–1957

A.T. McConnell, R. Ellis, B. Pathy, R. Plummer, P.E. Lovat, G. O’Boyle

The prognostic significance and impact of the CXCR4-CXCR7-CXCL12 axis in primary cutaneous melanoma

Br J Dermatol. 2016 Dec;175(6):1210–1220

D.Y.L Tang, R.A. Ellis, P.E. Lovat

Prognostic Impact of autophagy biomarkers for cutaneous melanoma

Front Oncol. 2016 Nov 9;6:236

S. Hernández-Tiedra, et al (P.E. Lovat author)

Dihydroceramide accumulation mediates cytotoxic autophagy of cancer cells via autolysosome destabilisation

Autophagy. 2016 Nov;12(11):2213–2229

D.S. Hill, N.D.P. Robinson, M.P. Caley, M. Chen, E.A. O’Toole, J.L. Armstrong, S. Przyborski, P.E. Lovat

A novel fully humanised 3D skin equivalent to model early melanoma invasion

Mol Cancer Ther. 2015 Nov;14(11):2665–73

J.L. Armstrong, D.S. Hill, C.S. McKee, S. Hernández-Tiedra, M. Lorente, I. Lopez-Valero, M.E. Anagnostou, F. Babatunde, M. Corazzari, C.P.F. Redfern, G. Velasco, P.E. Lovat

Exploiting cannabinoid-induced cytotoxic autophagy to drive melanoma cell death

J Invest Dermatol. 2015 Jun;135(6):1629–1637

M. Corazzari, F. Rapino, F. Ciccosanti, P. Giglio, M. Antonioli, B. Conti B, G.M. Fimia, P.E. Lovat, M. Piacentini

Oncogenic BRAF induces a chronic ER stress condition resulting in increased basal autophagy and apoptosis resistance of cutaneous melanoma

Cell Death Differ. 2015 Jun;22(6):946–58

P. Giglio, G.M. Fimia, P.E. Lovat, M. Piacentini, M. Corazzari

Fateful music from a talented orchestra with a wicked conductor: Connection between oncogenic BRAF, ER stress and autophagy in human melanoma

Mol Cell Oncol. 2015 Jan 26;2(3):e995016

D.S. Hill, P.E. Lovat, N.K. Haass

Induction of endoplasmic reticulum stress as a strategy for melanoma therapy: is there a future?

Melanoma Manag. 2014 Nov;1(2):127–137

Prognostic impact of p62 expression in cutaneous malignant melanoma

J Invest Dermatol. 2014 May;134(5):1476–1478

S. Verykiou, R.A. Ellis, P.E. Lovat

Established and emerging biomarkers in cutaneous malignant melanoma

Healthcare (Basel). 2014 Jan 14;2(1):60–73

M. Corazzari, G.M. Fimia, P. Lovat, M. Piacentini

Why is autophagy important in melanoma? Molecular mechanisms and therapeutic implications

Semin Cancer Biol. 2013 Oct;23(5):337–43

M. Corazzari, P.E. Lovat

Harnessing autophagy for melanoma benefit

Cell Biol: Res Ther 2013;2:1